Frequently Asked Questions
Respiratory Syncytial Virus (RSV) Diagnostics Market also suffered from the COVID 19 pandemic, which resulted in an increase in revenue generated in 2020 as growth brought on by the region’s rapidly expanding COVID-19 cases and the usage of RSV diagnostic kits to identify COVID-19.
The market for diagnostics for the respiratory syncytial virus (RSV) was dominated by North America.
The rise in the demand for point-of-care diagnostic tests for RSV-infected people and the advancement in the field of specific markers such as proteomics and genomics are the main factors that are anticipated to propel the growth of the respiratory syncytial virus (RSV) diagnostic market during the forecast period.
RSV Molecular Diagnostics had a major share in 2021.
The Hospitals had a major share in the global market in 2021.